Recursion outlines $800M cash runway through 2027 as leadership transition and partnership milestones drive next phase

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

Recursion Pharma Names Najat Khan to Succeed Chris Gibson as President, CEO

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...
STAT

Recursion CEO Chris Gibson out as company head after 12 years

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...
IEEE

Classification of Android Malware from Binary Code Using Ensemble Method with Recursive Feature Elimination

Abstract: In response to the burgeoning Android market and the concurrent proliferation of both applications and malware, we propose a direct analysis approach to classify Android malware by examining ...